Drug resistance can be evidenced histologically by the persistence of pathological features despite treatment. For instance, the continued presence of proliferating cells in a tumor might indicate resistance to a chemotherapeutic agent. Histological studies can also reveal cellular adaptations such as increased expression of drug efflux pumps or alterations in drug target molecules.
